Hipoalbuminemia sebagai prediktor luaran buruk pada pasien Guillain-Barre Syndrome (GBS)
Berkala NeuroSains · 2025
DOI: 10.22146/bns.v20i2.105960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Berkala NeuroSains, 2025. Verfasst von Yossy Catarina Budi Nur Syamsah und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Guillain-Barre Syndrome (GBS) is a neuropathic disease with mortality in 1.9–15% of patients and morbidity in more than 80% of patients who can walk unaided after 6 months. Plasma exchange (PE) is one of the GBS therapies that has clinical efficacy in improving disability and reducing mortality. The variable mortality and morbidity of GBS drives the need for biomarkers as predictors of GBS prognosis. One biomarker of interest is albumin. The autoimmune process of GBS involves an acute systemic inflammatory reaction that causes hypoalbuminemia. PE also causes a significant decrease in albumin levels.
Objective
This study aimed to find association between hypoalbuminemia at admission as a predictor of poor outcome of GBS patients undergoing PE.
Methods
This study used a retrospective cohort design. The population of this study were GBS patients with PE therapy at Dr. Sardjito Hospital. The study was conducted by comparing the Medical Research Council (MRC) score at admission with the outcome of the MRC score in patients with normal albumin levels (≥3.5 mg/dl) and hypoalbuminemia (
Zitieren
APA
Syamsah, Y. C. B. N., Harahap, I. S. K., & Paryono, P. (2025). Hipoalbuminemia sebagai prediktor luaran buruk pada pasien Guillain-Barre Syndrome (GBS). Berkala NeuroSains. https://doi.org/10.22146/bns.v20i2.105960
Vancouver
Syamsah YCBN, Harahap ISK, Paryono P. Hipoalbuminemia sebagai prediktor luaran buruk pada pasien Guillain-Barre Syndrome (GBS). Berkala NeuroSains. 2025. doi:10.22146/bns.v20i2.105960
BibTeX
@article{Syamsah2025,
author = {Syamsah, Yossy Catarina Budi Nur and Harahap, Indra Sari Kusuma and Paryono, Paryono},
title = {Hipoalbuminemia sebagai prediktor luaran buruk pada pasien Guillain-Barre Syndrome (GBS)},
journal = {Berkala NeuroSains},
year = {2025},
doi = {10.22146/bns.v20i2.105960}
}
EUVIMED